Astex awarded The Sunday Times Microsoft Tech Track 100 Research and Development Award 2004
Astex Technology, the fragment-based drug discovery and development company, received the Research and Development Award 2004 at the Sunday Times Microsoft Tech Track 100 awards ceremony held on the 30th November. The award recognises Astex's pioneering research and development into novel drugs to treat major diseases including cancer and Alzheimer's disease. Astex has ranked as the fastest growing UK biotechnology company in the Tech Track 100 league for the past two years and is one of a select few biotechnology companies to be included in the annual Tech Track 100 since its launch in 2001.
"It is an honour to receive the special award for Research and Development 2004 and to be ranked as Britain's top biotech company for the second year in a row in this prestigious listing of Britain's fastest growing technology companies. We're extremely proud of this special recognition of our achievements which is a tribute shared by everyone in the company," stated Mr. Timothy Haines, CEO of Astex.
Organizations
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.